The VASCADE Vascular Closure System was approved by the FDA in 2013 and approved for CE Marking in Europe 2012. Clinical data from a prospective, multi-center, randomized 420 patient trial demonstrated that VASCADE is clinically and statistically superior in both safety and efficacy compared to manual compression, the gold standard for vascular closure for patients undergoing percutaneous procedures through the femoral artery.